Pybus O, Drummond A, Nakano T, et al. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. MolBiolEvol. 2003;20(3):381–387.
2- García-Monzón C, Sánchez-Madrid F, García-Buey L, García-Arroyo A, et al. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tract. Gastroenterology 1995; 08: 231-41.
3- Yamaguchi R, Yano H, Nakashima O, et al. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2006;21:152–160.
4- Medina J, Arroyo AG, Sanchez-Madrid F, et al. Angiogenesis in chronic inflammatory liver disease. Hepatology 2004; 39: 1185-1195.
5- Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005; 42(Suppl): S22–36.
6- Medina J, Arroyo AG, Sanchez-Madrid F, et al. Angiogenesis in chronic inflammatory liver disease. Hepatology 2004; 39: 1185-1195.
7- Lai WK, Adams DH. Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease. J Hepatol 2005; 45: 7-11.
8- Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, et al. Vascular adhesion molecule expression in viral chronic hepatitis:evidence of neoangiogenesis in portal tracts. Gastroenterology 1995; 108: 231-241.
9- Hassan M, Selimovic D, Ghozlan H, et al.Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hepatology 2009;49(5):1469–82.
10- Abe M, Koga H, Yoshida T, et al. Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factorkB/ hypoxia-inducible factor-1a axis under hypoxic conditions Hepatology Research 2012; 42(6): 591–600.
11- Liang Y, Shilagard T, Xiao SY, et al. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 2009;137(4):1448–58.
12- Mukozu T, Nagal H, Matsui D, et al. Serum VEGF as a Tumor Marker in Patients with HCV-related Liver Cirrhosis and Hepatocellular Carcinoma. ANTICANCER RESEARCH 2013 ; 33: 1013-22.
13- Helaly GF, AbouShamaLA . Influence of hepatitis C virus infection on circulating sI CAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancingdetection of HCC. The Egyptian journal of immunology 2006; 13 (1) :27-38.
14- Janczewska-Kazek E, Marek B, KajdaniukD ,Borgiel-Marek H. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.World J Gastroenterol. 2006;12(6) : 961-5.
15- Sieghart W, Fellner S, Reiberger T, et al. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Dig Liver Dis 2009; 41(12):902–6.
16- Brdoskey SV, Mendolov N, Melamed M, Ramaswamy G. Vascular density and VEGF expression in hepatic lesions. J Gaterointestin Liver Dis 2007;16 (4):343-77.
17- Mohsen M. Maher, MD, Tarek Yossef, MD, Shereen A. Saleh, MD NesrineA Mohamed, MD, RamyAwara. Journal of medical science and clinical research 2015 ;3 (4):5070-5082.
18- Koff R, Younossi Z, Reddy R ,Shiffman M. Debate: hepatitis C with normal liver enzymes: to treat or not to treat. Am J Gastroenterol 2004;99(6):972-6.
19- De Ritis F, Coltorti M, Giusti G. Anenzymic test for the diagnosis of viral hepatitis: the transaminase serum activities. Clin. Chim. Acta 2006; 369 (2):148–52.
20- hiffman ML, Diago M, Tran A, et al.Chronic hepatitis C in patients withpersistently normal alanine transaminaselevels. Clin Gastroenterol Hepatol 2006;4(5):645-52.
21- Talaat RM. Soluble Angiogenesis Factors in Sera of Egyptian Patients with Hepatitis C Virus Infection: Correlation with Disease Severity.VIRAL IMMUNOLOGY 2010; 23 (2):151–7.
22- Assy N, Paizi M, Gaitini D et al. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol.1999 ;5(4):296-300.
23- Yao X, Miao W, Li M, et al. Protective effect of albumin on VEGF and brain edema in acute ischemia in rats. Neurosci Lett 2010 ;472(3): 179-83.
24- Chongsrisawata V, Vejchapipatb P, Poovorawana Y. Serum vascular endothelial growth factor per platelet count in patients with biliary atresia. Asian Biomedicine 2010; 4 (2) :223-9.
25- Kim SJ, Choi IK, Park KH, et al. Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival. J ClinOncol 2004; 34 (4): 184- 90.
26- GunsilusE, Gastle G. Platelets and vascular endothelial growth factor blood level in cancer patients. British Journal of Cancer 1999; 81 (1): 184-6